SNL BioSolutions ApS

Private limited companyCVR 44569272HellerupActive

SNL BioSolutions ApS is a private limited company, based in Hellerup, active in research and experimental development on natural sciences and engineering, founded in 2024. Equity was negative at the end of 2025 (−DKK 4.7m). The company made a loss in both 2024 and 2025, most recently DKK 1.8m. The company is new and has been registered for 2 years.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 607k+60.7% vs. 2024
Net profit−DKK 1.8m+54.9% vs. 2024
Equity−DKK 4.7m−22.2% vs. 2024
Employees3latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 3.9m to DKK 1.8m (2024 → 2025).

Management and owners, last 24 months

  • New in management: Dayanand Suryabhan Jadhav (board member, 03/12/2024) and Jarne Elleholm (chair of the board, 03/12/2024).
  • Stepped down: Jarne Elleholm (chair of the board, 01/04/2025).
  • New owners registered: SNLB Holding ApS (25/08/2025), Leeward ApS (03/12/2024) and SNLB Holding ApS (03/12/2024) (+1).
  • No longer registered as owner: SNLB Holding ApS (02/12/2024), Leeward ApS (01/07/2025) and SNLB Holding ApS (24/08/2025) (+1).

Registrations, last 24 months

  • 25/08/2025: Share capital changed from 446,316 DKK to 469,507 DKK
  • 09/04/2025: Share capital changed from 46,316 DKK to 446,316 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 03/12/2024: Share capital changed from 40,000 DKK to 46,316 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2024–2025 · amounts in DKK thousand

Equity and net profit

−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 020242025
EquityNet profit
Financial figures for SNL BioSolutions ApS
20242025Change
Revenuenot statednot stated–
Gross profit−1,543−607+60.7%
Operating profit (EBIT)−3,685−2,267+38.5%
Profit before tax−3,896−2,495+36%
Net profit−3,896−1,756+54.9%
Total assets881671−23.8%
Equity−3,850−4,707−22.2%
Liabilities4,7315,378+13.7%
Cash and cash equivalents751500−33.5%
Average number of employees63−50%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 2m−DKK 1.5m−DKK 1m−DKK 500kDKK 0DKK 500kDKK 1m20242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Negative equity

    Equity was −DKK 4.7m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

2 financial years
Annual reports for SNL BioSolutions ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202515/05/2026The companyPDF not statedXBRL
202417/01/2024 – 31/12/202403/06/2025The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123456703/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 607kNo. 302 of 421
Better than 28% of the companies in the industry
Equity−DKK 4.7mNo. 377 of 431
Better than 13% of the companies in the industry
Number of employees3No. 254 of 431
Better than 41% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 68,296of 69,742
Better than 2%
No. 69,122of 69,964
Better than 1%
Same industry and fewer than 20 employees329 companies in the comparison
No. 225of 323
Better than 30%
No. 286of 329
Better than 13%
Companies that are founded within the last five years16,662 companies in the comparison
No. 16,171of 16,614
Better than 3%
No. 16,480of 16,661
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 65,261of 66,379
Better than 2%
No. 65,661of 66,505
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. SNL BioSolutions ApS−DKK 607k
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. SNL BioSolutions ApS−DKK 1.8m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. SNL BioSolutions ApS−DKK 4.7m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. SNL BioSolutions ApS3
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • SNLB Holding ApS90%
SNL BioSolutions ApS

Management

2 active registrations

Executive management

Executive management at SNL BioSolutions ApS
NameRoleAppointed
Dayanand Suryabhan JadhavDirector17/01/2024

Board of directors

Board of directors at SNL BioSolutions ApS
NameRoleAppointed
Dayanand Suryabhan JadhavBoard member03/12/2024
Founders
SNLB Holding ApS
Former management (1)
Former management at SNL BioSolutions ApS
NameRoleAppointedResigned
Jarne ElleholmChair of the board03/12/202401/04/2025

Signing rule: Selskabet tegnes af direktøren.

Address and production units

1 active production units

Hagens Alle 7
2900 Hellerup

Gentofte Municipality · Postcode 2900

Production units
Production unitAddressEmployeesP number
SNL BioSolutions ApSHagens Alle 7, 2900 Hellerup31030011283

Purpose

Selskabets formål er at drive virksomhed med handel, service, produktion og blandt andet at have en væsentlig positiv indvirkning på samfundet og miljøet som helhed.

The purpose is quoted from the register in Danish.

Changes year by year

21 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20259 changescapital 2 · ownership 4 · accounts 1 · management 1 · industry 1
  • Share capital changed from 446,316 DKK to 469,507 DKK
  • SNLB Holding ApS registered as owner (90%)
  • Ambareesh Govind Phadnavis is no longer registered as owner
  • SNLB Holding ApS is no longer registered as owner
  • LEEWARD ApS is no longer registered as owner
  • Annual report for 2024 published
  • Share capital changed from 46,316 DKK to 446,316 DKK
  • Jarne Elleholm stepped down as chair of the board
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202411 changescapital 1 · management 3 · ownership 5 · industry 1 · founded 1
  • Share capital changed from 40,000 DKK to 46,316 DKK
  • Jarne Elleholm appointed chair of the board
  • Dayanand Suryabhan Jadhav appointed board member
  • LEEWARD ApS registered as owner (5%)
  • SNLB Holding ApS registered as owner (66.67%)
  • Ambareesh Govind Phadnavis registered as owner (5%)
  • SNLB Holding ApS is no longer registered as owner
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
  • Registered as SNL BioSolutions ApS
  • Dayanand Suryabhan Jadhav appointed director
  • SNLB Holding ApS registered as owner (100%)

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction